Skip to main content
Clinical Trials/NL-OMON25044
NL-OMON25044SuspendedNot Applicable

OSTRADAMUS: Testing for thrombophilia in patients with a first episode of venous thromboembolism: a randomized controlled trial to assess effects on clinical outcomes, quality of life, and costs.

ZonMwNederlandse Hartstichting (Dutch Heart foundation)0 sites1,336 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Suspended
Sponsor
Enrollment
1,336

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Subjects must be willing and able to give written informed consent
  • 2. Confirmed symptomatic DVT, i.e., proximal vein or extensive calf-vein
  • thrombosis, involving at least the upper third part of the deep calf veins (trifurcation, AND/OR confirmed symptomatic PE, no longer than 2 months prior to randomization

Exclusion Criteria

  • 1. Previous episodes of DVT or PE
  • 2. Active bleeding or high risk for bleeding contraindicating treatment with LMWH, fondaparinux or VKA

Investigators

Sponsor
ZonMwNederlandse Hartstichting (Dutch Heart foundation)

Similar Trials